CRISPR Therapeutics (Nasdaq: CRSP), today announced that a poster presentation highlighting the Company’s Phase 1 clinical ...
Gene-editing techniques could soon allow researchers to replace entire genes and engineer complex cellular circuits — if the ...
CRISPR-Cas9 has transformed the life sciences by giving researchers a seemingly simple tool for cutting DNA at chosen ...
NEW ORLEANS, LA—An investigational CRISPR-Cas9 gene-editing therapy that targets angiopoietin-like protein 3 (ANGPTL3), which has a role in regulating lipid metabolism, appears to safely lower levels ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
The AI company Anthropic has announced that its Claude large language model has discovered a system reminiscent of CRISPR, ...
Morning Overview on MSN
One CRISPR shot cut 'bad' cholesterol in half and it lasted a full year
A single intravenous infusion of an experimental CRISPR-Cas9 therapy cut LDL cholesterol by 52.5% in patients who received ...
A tiny molecular scissor that once barely worked in human cells has been transformed into a high-performance genome-editing ...
Don't read too much into this year's lackluster performance. Near-term catalysts are firming up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results